Venatorx Pharmaceuticals is a private pharmaceutical company focused on improving health outcomes for patients with multi-drug-resistant bacterial infections and hard-to-treat viral infections.
Location: United States, Pennsylvania, Malvern
Employees: 51-200
Total raised: $42M
Founded date: 2010
Investors 4
| Date | Name | Website |
| - | Foresite C... | foresiteca... |
| - | BioAdvance | bioadvance... |
| - | Abingworth... | abingworth... |
| - | CARB-X | carb-x.org |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.07.2017 | Series B | $42M | Foresite C... |
Mentions in press and media 18
| Date | Title | Description | Source |
| 09.01.2024 | Venatorx Pharmaceuticals and Menarini Group Enter Commercial... | MALVERN, Pa. and FLORENCE, Italy, Jan. 9, 2024 /PRNewswire/ -- Venatorx Pharmaceuticals, a private, ... | en.prnasia... |
| 15.08.2023 | Everest Medicines' Partner Venatorx Receives FDA Acceptance ... | SHANGHAI, Aug. 15, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK)'s partner Venatorx Pharmace... | en.prnasia... |
| 04.04.2022 | Big Pharma-backed $1B AMR Action Fund picks 1st antimicrobia... | The AMR Action Fund, backed by Big Pharmas such as Pfizer, Eli Lilly, Bayer and more, has selected t... | fiercebiot... |
| 04.04.2022 | Venatorx Pharmaceuticals Raises Series C Financing | Venatorx Pharmaceuticals, Inc., a Malvern, PA-based private, clinical-stage pharmaceutical company f... | finsmes.co... |
| 10.03.2022 | Everest Medicines Announces that Licensing Partner Venatorx ... | SHANGHAI, March 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its l... | en.prnasia... |
| 02.07.2021 | CureVac gains COO and hands Florian von der Mülbe new as... | Malte Greune → Aiming to bounce back and trying to accentuate the positive after its mRNA... | endpts.com... |
| 04.08.2020 | Could Drug-Resistant Bacteria Cause The Next Pandemic? | Venetians dressed as plague doctors pose during Carnival in their city's Piazza San Marco on ... [+]... | forbes.com... |
| 21.08.2017 | VenatoRx Pharmaceuticals Raises $42M in Series B Funding | VenatoRx Pharmaceuticals, Inc., a Malvern, PA-based biopharmaceutical company developing next‐genera... | finsmes.co... |
| 26.07.2017 | VenatoRx Pharmaceuticals Nabs $42 Million | MALVERN, PA, VenatoRx Pharmaceuticals, Inc., a biopharmaceutical company developing next-generatio... | vcnewsdail... |
| 25.07.2017 | VenatoRx raises $42M to take drug for breaking bacterial res... | VenatoRx Pharmaceuticals has raised $42 million to fund antibiotic R&D. The series B equips the ... | fiercebiot... |
Show more